Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Gaglio

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Oncotarget|July 14, 2016
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry studyDaniela Gaglio, Silvia Valtorta, Marilena Ripamonti, et al.
Cancer & Metabolism|October 2, 2020
Disruption of redox homeostasis for combinatorial drug efficacy in <i>K-Ras</i> tumors as revealed by metabolic connectivity profilingDaniela Gaglio, Marcella Bonanomi, Silvia Valtorta, et al.
Communications Biology|May 23, 2026
FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approachGiacomo Ducci, Giorgia Ciufolini, Gloria Campioni, et al.
Nature Communications|July 6, 2026
Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infectionAmanda Facoetti, Luca Lambroia, Elena Fontana, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Oncotarget|July 14, 2016
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry studyDaniela Gaglio, Silvia Valtorta, Marilena Ripamonti, et al.
Cancer & Metabolism|October 2, 2020
Disruption of redox homeostasis for combinatorial drug efficacy in <i>K-Ras</i> tumors as revealed by metabolic connectivity profilingDaniela Gaglio, Marcella Bonanomi, Silvia Valtorta, et al.
Communications Biology|May 23, 2026
FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approachGiacomo Ducci, Giorgia Ciufolini, Gloria Campioni, et al.
Nature Communications|July 6, 2026
Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infectionAmanda Facoetti, Luca Lambroia, Elena Fontana, et al.
Pageof 5